Page last updated: 2024-10-19

thioctic acid and Pulmonary Disease, Chronic Obstructive

thioctic acid has been researched along with Pulmonary Disease, Chronic Obstructive in 1 studies

Thioctic Acid: An octanoic acid bridged with two sulfurs so that it is sometimes also called a pentanoic acid in some naming schemes. It is biosynthesized by cleavage of LINOLEIC ACID and is a coenzyme of oxoglutarate dehydrogenase (KETOGLUTARATE DEHYDROGENASE COMPLEX). It is used in DIETARY SUPPLEMENTS.

Pulmonary Disease, Chronic Obstructive: A disease of chronic diffuse irreversible airflow obstruction. Subcategories of COPD include CHRONIC BRONCHITIS and PULMONARY EMPHYSEMA.

Research Excerpts

ExcerptRelevanceReference
"Ten patients with COPD performed knee extensor exercise to exhaustion and isotime trials after either the AOC or placebo (PL)."2.78Oxidative stress and COPD: the effect of oral antioxidants on skeletal muscle fatigue. ( Amann, M; Groot, HJ; Reese, V; Richardson, RS; Rossman, MJ; Zhao, J, 2013)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Rossman, MJ1
Groot, HJ1
Reese, V1
Zhao, J1
Amann, M1
Richardson, RS1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Effects of Oral Antioxidant Cocktail on Vascular Function and Blood Flow in Cardiovascular Disease Patients[NCT03629613]0 participants (Actual)Interventional2020-12-01Withdrawn (stopped due to discontinued due to change in operating plans prior to study initiation and enrollment)
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trials

1 trial available for thioctic acid and Pulmonary Disease, Chronic Obstructive

ArticleYear
Oxidative stress and COPD: the effect of oral antioxidants on skeletal muscle fatigue.
    Medicine and science in sports and exercise, 2013, Volume: 45, Issue:7

    Topics: Administration, Oral; Aged; Antioxidants; Ascorbic Acid; Biomarkers; Drug Administration Schedule; D

2013